Echinacea purpurea for the long-term prevention of viral respiratory tract infections during COVID-19 pandemic: A randomized, open, controlled clinical study
Zeitschrift fur Phytotherapie
; 43:S47-S48, 2022.
Article
in English
| EMBASE | ID: covidwho-1967699
acute disease; adult; aged; antiviral activity; blood sampling; conference abstract; controlled study; coronavirus disease 2019; Echinacea purpurea; female; human; major clinical study; male; nonhuman; open study; pandemic; physical disease by body function; prevention; randomized controlled trial; respiratory tract infection; respiratory virus; Severe acute respiratory syndrome coronavirus 2; vaccination; venous blood; viral clearance; viral respiratory tract infection; virus load
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
/
Vaccines
Language:
English
Journal:
Zeitschrift fur Phytotherapie
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS